nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—HTR7—pulmonary artery—dilated cardiomyopathy	0.00822	0.165	CbGeAlD
Quetiapine—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.00799	0.16	CbGeAlD
Quetiapine—Trifluoperazine—TNNC1—dilated cardiomyopathy	0.00588	0.849	CrCbGaD
Quetiapine—HTR2A—pulmonary artery—dilated cardiomyopathy	0.00513	0.103	CbGeAlD
Quetiapine—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.00499	0.0998	CbGeAlD
Quetiapine—DRD4—heart—dilated cardiomyopathy	0.00357	0.0714	CbGeAlD
Quetiapine—Drug interaction—Furosemide—dilated cardiomyopathy	0.00333	0.00674	CcSEcCtD
Quetiapine—Gout—Furosemide—dilated cardiomyopathy	0.00331	0.00669	CcSEcCtD
Quetiapine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00328	0.00664	CcSEcCtD
Quetiapine—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.00321	0.00651	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00315	0.00637	CcSEcCtD
Quetiapine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00296	0.006	CcSEcCtD
Quetiapine—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00284	0.00574	CcSEcCtD
Quetiapine—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.0028	0.00566	CcSEcCtD
Quetiapine—Urine output increased—Furosemide—dilated cardiomyopathy	0.00279	0.00565	CcSEcCtD
Quetiapine—Bladder pain—Furosemide—dilated cardiomyopathy	0.00279	0.00565	CcSEcCtD
Quetiapine—H1F0—cardiac ventricle—dilated cardiomyopathy	0.00277	0.0555	CbGeAlD
Quetiapine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.0027	0.00545	CcSEcCtD
Quetiapine—Mental disability—Furosemide—dilated cardiomyopathy	0.00268	0.00542	CcSEcCtD
Quetiapine—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00262	0.0053	CcSEcCtD
Quetiapine—H1F0—myocardium—dilated cardiomyopathy	0.00261	0.0522	CbGeAlD
Quetiapine—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00259	0.00524	CcSEcCtD
Quetiapine—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00258	0.00522	CcSEcCtD
Quetiapine—Polyuria—Furosemide—dilated cardiomyopathy	0.00255	0.00517	CcSEcCtD
Quetiapine—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00255	0.00516	CcSEcCtD
Quetiapine—Cough increased—Lisinopril—dilated cardiomyopathy	0.00253	0.00512	CcSEcCtD
Quetiapine—Deafness—Furosemide—dilated cardiomyopathy	0.00251	0.00507	CcSEcCtD
Quetiapine—Drug interaction—Lisinopril—dilated cardiomyopathy	0.0025	0.00505	CcSEcCtD
Quetiapine—Gout—Lisinopril—dilated cardiomyopathy	0.00248	0.00502	CcSEcCtD
Quetiapine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00247	0.00499	CcSEcCtD
Quetiapine—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00243	0.00493	CcSEcCtD
Quetiapine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00239	0.00483	CcSEcCtD
Quetiapine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00238	0.00481	CcSEcCtD
Quetiapine—Thirst—Furosemide—dilated cardiomyopathy	0.00236	0.00477	CcSEcCtD
Quetiapine—Neck pain—Lisinopril—dilated cardiomyopathy	0.00235	0.00475	CcSEcCtD
Quetiapine—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00232	0.00469	CcSEcCtD
Quetiapine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0023	0.00466	CcSEcCtD
Quetiapine—Lethargy—Furosemide—dilated cardiomyopathy	0.00229	0.00463	CcSEcCtD
Quetiapine—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00226	0.00458	CcSEcCtD
Quetiapine—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00225	0.00455	CcSEcCtD
Quetiapine—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00225	0.00455	CcSEcCtD
Quetiapine—Malaise—Spironolactone—dilated cardiomyopathy	0.00224	0.00453	CcSEcCtD
Quetiapine—Cystitis—Lisinopril—dilated cardiomyopathy	0.00224	0.00453	CcSEcCtD
Quetiapine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00222	0.0045	CcSEcCtD
Quetiapine—Irritability—Furosemide—dilated cardiomyopathy	0.00214	0.00433	CcSEcCtD
Quetiapine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00213	0.00431	CcSEcCtD
Quetiapine—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.0021	0.00425	CcSEcCtD
Quetiapine—Bladder pain—Lisinopril—dilated cardiomyopathy	0.0021	0.00424	CcSEcCtD
Quetiapine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00209	0.00422	CcSEcCtD
Quetiapine—Dehydration—Furosemide—dilated cardiomyopathy	0.00208	0.00422	CcSEcCtD
Quetiapine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00205	0.00414	CcSEcCtD
Quetiapine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00204	0.00413	CcSEcCtD
Quetiapine—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00204	0.00413	CcSEcCtD
Quetiapine—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00203	0.00411	CcSEcCtD
Quetiapine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00203	0.0041	CcSEcCtD
Quetiapine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00202	0.00409	CcSEcCtD
Quetiapine—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00202	0.00409	CcSEcCtD
Quetiapine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00198	0.00401	CcSEcCtD
Quetiapine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00198	0.004	CcSEcCtD
Quetiapine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00195	0.00395	CcSEcCtD
Quetiapine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00194	0.00393	CcSEcCtD
Quetiapine—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00193	0.00391	CcSEcCtD
Quetiapine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00192	0.00388	CcSEcCtD
Quetiapine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.0019	0.00384	CcSEcCtD
Quetiapine—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.0019	0.00384	CcSEcCtD
Quetiapine—Eczema—Lisinopril—dilated cardiomyopathy	0.00187	0.00379	CcSEcCtD
Quetiapine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00185	0.00374	CcSEcCtD
Quetiapine—Injury—Lisinopril—dilated cardiomyopathy	0.00183	0.0037	CcSEcCtD
Quetiapine—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00182	0.00369	CcSEcCtD
Quetiapine—H1F0—heart—dilated cardiomyopathy	0.00182	0.0364	CbGeAlD
Quetiapine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00181	0.00367	CcSEcCtD
Quetiapine—Somnolence—Spironolactone—dilated cardiomyopathy	0.0018	0.00364	CcSEcCtD
Quetiapine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00179	0.00362	CcSEcCtD
Quetiapine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00178	0.00359	CcSEcCtD
Quetiapine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00177	0.00358	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00175	0.00354	CcSEcCtD
Quetiapine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00175	0.00354	CcSEcCtD
Quetiapine—Arthritis—Lisinopril—dilated cardiomyopathy	0.00173	0.0035	CcSEcCtD
Quetiapine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00172	0.00349	CcSEcCtD
Quetiapine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00172	0.00347	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00171	0.00347	CcSEcCtD
Quetiapine—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00169	0.00342	CcSEcCtD
Quetiapine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00168	0.0034	CcSEcCtD
Quetiapine—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00168	0.0034	CcSEcCtD
Quetiapine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00167	0.00338	CcSEcCtD
Quetiapine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00167	0.00338	CcSEcCtD
Quetiapine—Sweating—Furosemide—dilated cardiomyopathy	0.00166	0.00335	CcSEcCtD
Quetiapine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00163	0.00331	CcSEcCtD
Quetiapine—Face oedema—Lisinopril—dilated cardiomyopathy	0.00162	0.00329	CcSEcCtD
Quetiapine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00161	0.00326	CcSEcCtD
Quetiapine—Irritability—Lisinopril—dilated cardiomyopathy	0.00161	0.00325	CcSEcCtD
Quetiapine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0016	0.00324	CcSEcCtD
Quetiapine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.0016	0.00324	CcSEcCtD
Quetiapine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00158	0.0032	CcSEcCtD
Quetiapine—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00158	0.00319	CcSEcCtD
Quetiapine—ADRA2C—cardiac ventricle—dilated cardiomyopathy	0.00157	0.0315	CbGeAlD
Quetiapine—Dehydration—Lisinopril—dilated cardiomyopathy	0.00156	0.00317	CcSEcCtD
Quetiapine—H1F0—cardiac atrium—dilated cardiomyopathy	0.00156	0.0311	CbGeAlD
Quetiapine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00154	0.00311	CcSEcCtD
Quetiapine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00153	0.0031	CcSEcCtD
Quetiapine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00152	0.00308	CcSEcCtD
Quetiapine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00152	0.00308	CcSEcCtD
Quetiapine—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00151	0.00307	CcSEcCtD
Quetiapine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00151	0.00307	CcSEcCtD
Quetiapine—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.0015	0.00304	CcSEcCtD
Quetiapine—Visual impairment—Furosemide—dilated cardiomyopathy	0.00149	0.00302	CcSEcCtD
Quetiapine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00149	0.00302	CcSEcCtD
Quetiapine—Gastritis—Lisinopril—dilated cardiomyopathy	0.00149	0.00301	CcSEcCtD
Quetiapine—ADRA2C—myocardium—dilated cardiomyopathy	0.00148	0.0296	CbGeAlD
Quetiapine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00147	0.00297	CcSEcCtD
Quetiapine—Asthma—Lisinopril—dilated cardiomyopathy	0.00145	0.00294	CcSEcCtD
Quetiapine—Influenza—Lisinopril—dilated cardiomyopathy	0.00145	0.00294	CcSEcCtD
Quetiapine—Eye disorder—Furosemide—dilated cardiomyopathy	0.00145	0.00293	CcSEcCtD
Quetiapine—CHRM2—heart—dilated cardiomyopathy	0.00145	0.029	CbGeAlD
Quetiapine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00145	0.00293	CcSEcCtD
Quetiapine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00144	0.00291	CcSEcCtD
Quetiapine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00143	0.0029	CcSEcCtD
Quetiapine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00143	0.00288	CcSEcCtD
Quetiapine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00142	0.00287	CcSEcCtD
Quetiapine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00141	0.00285	CcSEcCtD
Quetiapine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.0014	0.00283	CcSEcCtD
Quetiapine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.0014	0.00283	CcSEcCtD
Quetiapine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00139	0.0028	CcSEcCtD
Quetiapine—Dysuria—Lisinopril—dilated cardiomyopathy	0.00136	0.00275	CcSEcCtD
Quetiapine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00136	0.00275	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00135	0.00273	CcSEcCtD
Quetiapine—Malnutrition—Furosemide—dilated cardiomyopathy	0.00135	0.00273	CcSEcCtD
Quetiapine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00134	0.00271	CcSEcCtD
Quetiapine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00134	0.00271	CcSEcCtD
Quetiapine—Flatulence—Furosemide—dilated cardiomyopathy	0.00133	0.00269	CcSEcCtD
Quetiapine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00133	0.00269	CcSEcCtD
Quetiapine—Weight increased—Lisinopril—dilated cardiomyopathy	0.00132	0.00268	CcSEcCtD
Quetiapine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00132	0.00268	CcSEcCtD
Quetiapine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00132	0.00266	CcSEcCtD
Quetiapine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00131	0.00265	CcSEcCtD
Quetiapine—Pneumonia—Lisinopril—dilated cardiomyopathy	0.0013	0.00264	CcSEcCtD
Quetiapine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.0013	0.00263	CcSEcCtD
Quetiapine—Depression—Lisinopril—dilated cardiomyopathy	0.00129	0.00262	CcSEcCtD
Quetiapine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00129	0.00261	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00129	0.0026	CcSEcCtD
Quetiapine—Rash—Spironolactone—dilated cardiomyopathy	0.00128	0.00258	CcSEcCtD
Quetiapine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00128	0.00258	CcSEcCtD
Quetiapine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00127	0.00257	CcSEcCtD
Quetiapine—Headache—Spironolactone—dilated cardiomyopathy	0.00127	0.00257	CcSEcCtD
Quetiapine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00126	0.00256	CcSEcCtD
Quetiapine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00126	0.00255	CcSEcCtD
Quetiapine—Anaemia—Furosemide—dilated cardiomyopathy	0.00125	0.00253	CcSEcCtD
Quetiapine—Sweating—Lisinopril—dilated cardiomyopathy	0.00124	0.00251	CcSEcCtD
Quetiapine—Agitation—Furosemide—dilated cardiomyopathy	0.00124	0.00251	CcSEcCtD
Quetiapine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00123	0.00248	CcSEcCtD
Quetiapine—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00122	0.00247	CcSEcCtD
Quetiapine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00122	0.00246	CcSEcCtD
Quetiapine—Vertigo—Furosemide—dilated cardiomyopathy	0.00121	0.00245	CcSEcCtD
Quetiapine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00121	0.00245	CcSEcCtD
Quetiapine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00121	0.00245	CcSEcCtD
Quetiapine—Nausea—Spironolactone—dilated cardiomyopathy	0.0012	0.00243	CcSEcCtD
Quetiapine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00118	0.0024	CcSEcCtD
Quetiapine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00117	0.00236	CcSEcCtD
Quetiapine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00116	0.00235	CcSEcCtD
Quetiapine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00116	0.00234	CcSEcCtD
Quetiapine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00115	0.00234	CcSEcCtD
Quetiapine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00115	0.00233	CcSEcCtD
Quetiapine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00115	0.00232	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00114	0.00231	CcSEcCtD
Quetiapine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00114	0.00231	CcSEcCtD
Quetiapine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00112	0.00227	CcSEcCtD
Quetiapine—HTR7—heart—dilated cardiomyopathy	0.00112	0.0225	CbGeAlD
Quetiapine—Confusional state—Furosemide—dilated cardiomyopathy	0.00111	0.00225	CcSEcCtD
Quetiapine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.0011	0.00223	CcSEcCtD
Quetiapine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.0011	0.00223	CcSEcCtD
Quetiapine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00109	0.0022	CcSEcCtD
Quetiapine—Shock—Furosemide—dilated cardiomyopathy	0.00108	0.00219	CcSEcCtD
Quetiapine—ADRA1A—heart—dilated cardiomyopathy	0.00108	0.0217	CbGeAlD
Quetiapine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00108	0.00219	CcSEcCtD
Quetiapine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00108	0.00218	CcSEcCtD
Quetiapine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00107	0.00217	CcSEcCtD
Quetiapine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00107	0.00216	CcSEcCtD
Quetiapine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00106	0.00214	CcSEcCtD
Quetiapine—Anorexia—Furosemide—dilated cardiomyopathy	0.00105	0.00213	CcSEcCtD
Quetiapine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00105	0.00212	CcSEcCtD
Quetiapine—Chills—Lisinopril—dilated cardiomyopathy	0.00104	0.00211	CcSEcCtD
Quetiapine—Loxapine—ADRB1—dilated cardiomyopathy	0.00104	0.151	CrCbGaD
Quetiapine—ADRA2C—heart—dilated cardiomyopathy	0.00103	0.0206	CbGeAlD
Quetiapine—Hypotension—Furosemide—dilated cardiomyopathy	0.00103	0.00208	CcSEcCtD
Quetiapine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00102	0.00206	CcSEcCtD
Quetiapine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00101	0.00205	CcSEcCtD
Quetiapine—Flatulence—Lisinopril—dilated cardiomyopathy	0.000998	0.00202	CcSEcCtD
Quetiapine—Tension—Lisinopril—dilated cardiomyopathy	0.000994	0.00201	CcSEcCtD
Quetiapine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000992	0.00201	CcSEcCtD
Quetiapine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000989	0.002	CcSEcCtD
Quetiapine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000984	0.00199	CcSEcCtD
Quetiapine—Back pain—Lisinopril—dilated cardiomyopathy	0.00098	0.00198	CcSEcCtD
Quetiapine—Somnolence—Furosemide—dilated cardiomyopathy	0.00098	0.00198	CcSEcCtD
Quetiapine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000974	0.00197	CcSEcCtD
Quetiapine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000958	0.00194	CcSEcCtD
Quetiapine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000955	0.00193	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000951	0.00193	CcSEcCtD
Quetiapine—Fatigue—Furosemide—dilated cardiomyopathy	0.00095	0.00192	CcSEcCtD
Quetiapine—Tremor—Lisinopril—dilated cardiomyopathy	0.000949	0.00192	CcSEcCtD
Quetiapine—Constipation—Furosemide—dilated cardiomyopathy	0.000942	0.00191	CcSEcCtD
Quetiapine—Pain—Furosemide—dilated cardiomyopathy	0.000942	0.00191	CcSEcCtD
Quetiapine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00094	0.0019	CcSEcCtD
Quetiapine—Anaemia—Lisinopril—dilated cardiomyopathy	0.000936	0.00189	CcSEcCtD
Quetiapine—Angioedema—Lisinopril—dilated cardiomyopathy	0.000926	0.00187	CcSEcCtD
Quetiapine—Malaise—Lisinopril—dilated cardiomyopathy	0.000914	0.00185	CcSEcCtD
Quetiapine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00091	0.00184	CcSEcCtD
Quetiapine—Syncope—Lisinopril—dilated cardiomyopathy	0.000908	0.00184	CcSEcCtD
Quetiapine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000908	0.00184	CcSEcCtD
Quetiapine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000907	0.00183	CcSEcCtD
Quetiapine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000901	0.00182	CcSEcCtD
Quetiapine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000895	0.00181	CcSEcCtD
Quetiapine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00089	0.0018	CcSEcCtD
Quetiapine—Cough—Lisinopril—dilated cardiomyopathy	0.000884	0.00179	CcSEcCtD
Quetiapine—ADRA2C—cardiac atrium—dilated cardiomyopathy	0.000882	0.0177	CbGeAlD
Quetiapine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000871	0.00176	CcSEcCtD
Quetiapine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000871	0.00176	CcSEcCtD
Quetiapine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000862	0.00175	CcSEcCtD
Quetiapine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000862	0.00175	CcSEcCtD
Quetiapine—Myalgia—Lisinopril—dilated cardiomyopathy	0.000862	0.00175	CcSEcCtD
Quetiapine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000859	0.00174	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000857	0.00173	CcSEcCtD
Quetiapine—Discomfort—Lisinopril—dilated cardiomyopathy	0.000852	0.00172	CcSEcCtD
Quetiapine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000843	0.00171	CcSEcCtD
Quetiapine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000834	0.00169	CcSEcCtD
Quetiapine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000827	0.00167	CcSEcCtD
Quetiapine—ADRA2A—heart—dilated cardiomyopathy	0.000823	0.0165	CbGeAlD
Quetiapine—Infection—Lisinopril—dilated cardiomyopathy	0.000821	0.00166	CcSEcCtD
Quetiapine—Shock—Lisinopril—dilated cardiomyopathy	0.000813	0.00165	CcSEcCtD
Quetiapine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000812	0.00164	CcSEcCtD
Quetiapine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000809	0.00164	CcSEcCtD
Quetiapine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000807	0.00163	CcSEcCtD
Quetiapine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000803	0.00163	CcSEcCtD
Quetiapine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000799	0.00162	CcSEcCtD
Quetiapine—Asthenia—Furosemide—dilated cardiomyopathy	0.000791	0.0016	CcSEcCtD
Quetiapine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000788	0.00159	CcSEcCtD
Quetiapine—Pruritus—Furosemide—dilated cardiomyopathy	0.00078	0.00158	CcSEcCtD
Quetiapine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000773	0.00156	CcSEcCtD
Quetiapine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000754	0.00153	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000753	0.00152	CcSEcCtD
Quetiapine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000748	0.00151	CcSEcCtD
Quetiapine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000742	0.0015	CcSEcCtD
Quetiapine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000737	0.00149	CcSEcCtD
Quetiapine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000735	0.00149	CcSEcCtD
Quetiapine—Dizziness—Furosemide—dilated cardiomyopathy	0.000729	0.00147	CcSEcCtD
Quetiapine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000728	0.00147	CcSEcCtD
Quetiapine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000719	0.00145	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000714	0.00144	CcSEcCtD
Quetiapine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000713	0.00144	CcSEcCtD
Quetiapine—Constipation—Lisinopril—dilated cardiomyopathy	0.000707	0.00143	CcSEcCtD
Quetiapine—Pain—Lisinopril—dilated cardiomyopathy	0.000707	0.00143	CcSEcCtD
Quetiapine—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.000704	0.0141	CbGeAlD
Quetiapine—Vomiting—Furosemide—dilated cardiomyopathy	0.000701	0.00142	CcSEcCtD
Quetiapine—HTR2A—heart—dilated cardiomyopathy	0.0007	0.014	CbGeAlD
Quetiapine—Rash—Furosemide—dilated cardiomyopathy	0.000695	0.00141	CcSEcCtD
Quetiapine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000694	0.0014	CcSEcCtD
Quetiapine—Headache—Furosemide—dilated cardiomyopathy	0.00069	0.0014	CcSEcCtD
Quetiapine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000681	0.00138	CcSEcCtD
Quetiapine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000676	0.00137	CcSEcCtD
Quetiapine—Nausea—Furosemide—dilated cardiomyopathy	0.000655	0.00132	CcSEcCtD
Quetiapine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000654	0.00132	CcSEcCtD
Quetiapine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000654	0.00132	CcSEcCtD
Quetiapine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000609	0.00123	CcSEcCtD
Quetiapine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000593	0.0012	CcSEcCtD
Quetiapine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000585	0.00118	CcSEcCtD
Quetiapine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000566	0.00114	CcSEcCtD
Quetiapine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000547	0.00111	CcSEcCtD
Quetiapine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000526	0.00106	CcSEcCtD
Quetiapine—Rash—Lisinopril—dilated cardiomyopathy	0.000521	0.00105	CcSEcCtD
Quetiapine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000521	0.00105	CcSEcCtD
Quetiapine—Headache—Lisinopril—dilated cardiomyopathy	0.000518	0.00105	CcSEcCtD
Quetiapine—Nausea—Lisinopril—dilated cardiomyopathy	0.000491	0.000994	CcSEcCtD
Quetiapine—ABCB1—heart—dilated cardiomyopathy	0.000459	0.00918	CbGeAlD
Quetiapine—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.33e-05	9.65e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.31e-05	9.59e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.3e-05	9.58e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.29e-05	9.55e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.28e-05	9.52e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.27e-05	9.51e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.26e-05	9.49e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.26e-05	9.49e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.24e-05	9.44e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.22e-05	9.4e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.21e-05	9.38e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.2e-05	9.37e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.2e-05	9.36e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.2e-05	9.35e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	4.17e-05	9.3e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.17e-05	9.28e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.16e-05	9.26e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.15e-05	9.24e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.15e-05	9.24e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.13e-05	9.21e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.13e-05	9.21e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.11e-05	9.17e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	4.11e-05	9.15e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.1e-05	9.14e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	4.1e-05	9.13e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.09e-05	9.12e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	4.09e-05	9.1e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.08e-05	9.09e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.08e-05	9.09e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.08e-05	9.09e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	4.07e-05	9.07e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.04e-05	8.99e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	4.03e-05	8.98e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.03e-05	8.97e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.03e-05	8.97e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	4.02e-05	8.96e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.02e-05	8.94e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	4e-05	8.92e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.99e-05	8.89e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—RAC1—dilated cardiomyopathy	3.97e-05	8.85e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.97e-05	8.84e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.97e-05	8.84e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	3.97e-05	8.84e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.96e-05	8.83e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.96e-05	8.82e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.95e-05	8.8e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	3.94e-05	8.78e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.92e-05	8.74e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.91e-05	8.71e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.86e-05	8.6e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	3.86e-05	8.59e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—RAF1—dilated cardiomyopathy	3.85e-05	8.59e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.84e-05	8.55e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	3.82e-05	8.5e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.8e-05	8.47e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—RAC1—dilated cardiomyopathy	3.8e-05	8.46e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AGT—dilated cardiomyopathy	3.79e-05	8.45e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.79e-05	8.45e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	3.79e-05	8.44e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.79e-05	8.43e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.79e-05	8.43e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.79e-05	8.43e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.78e-05	8.43e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.77e-05	8.39e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	3.77e-05	8.39e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—RAC1—dilated cardiomyopathy	3.75e-05	8.34e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	3.74e-05	8.32e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.73e-05	8.32e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.73e-05	8.32e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	3.72e-05	8.28e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	3.71e-05	8.26e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	3.69e-05	8.21e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.67e-05	8.18e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.66e-05	8.16e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AGT—dilated cardiomyopathy	3.63e-05	8.08e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	3.61e-05	8.04e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.61e-05	8.03e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	3.59e-05	7.99e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AGT—dilated cardiomyopathy	3.58e-05	7.97e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.5e-05	7.81e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.45e-05	7.68e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.44e-05	7.66e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.43e-05	7.64e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	3.43e-05	7.63e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.42e-05	7.61e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.42e-05	7.61e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.42e-05	7.61e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—RAF1—dilated cardiomyopathy	3.41e-05	7.6e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.39e-05	7.54e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.38e-05	7.52e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	3.37e-05	7.51e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	3.37e-05	7.51e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.37e-05	7.51e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	3.35e-05	7.45e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.32e-05	7.4e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.3e-05	7.35e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.28e-05	7.31e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	3.28e-05	7.31e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.27e-05	7.29e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	3.27e-05	7.27e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.26e-05	7.27e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.25e-05	7.25e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.25e-05	7.25e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	3.25e-05	7.24e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.24e-05	7.22e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.24e-05	7.21e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	3.22e-05	7.18e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	3.22e-05	7.18e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.21e-05	7.15e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.2e-05	7.13e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—CD36—dilated cardiomyopathy	3.2e-05	7.12e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.19e-05	7.11e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.15e-05	7.01e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.14e-05	7e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.14e-05	6.99e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.1e-05	6.9e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.06e-05	6.81e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.05e-05	6.8e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	3.04e-05	6.78e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.03e-05	6.76e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	3.01e-05	6.71e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.98e-05	6.63e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.97e-05	6.62e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.94e-05	6.55e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	2.93e-05	6.53e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	2.92e-05	6.51e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.92e-05	6.51e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	2.91e-05	6.48e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.9e-05	6.45e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.88e-05	6.42e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AGT—dilated cardiomyopathy	2.88e-05	6.41e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.86e-05	6.36e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.85e-05	6.35e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	2.84e-05	6.34e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.84e-05	6.34e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.84e-05	6.31e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.83e-05	6.29e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.81e-05	6.26e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	2.81e-05	6.26e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.8e-05	6.25e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	2.8e-05	6.24e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.8e-05	6.23e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.8e-05	6.23e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	2.79e-05	6.22e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.79e-05	6.22e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.79e-05	6.21e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.76e-05	6.15e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.76e-05	6.15e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	2.76e-05	6.15e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.75e-05	6.13e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	2.72e-05	6.05e-05	CbGpPWpGaD
Quetiapine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.7e-05	6.02e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	2.69e-05	5.98e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	2.67e-05	5.96e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—EGFR—dilated cardiomyopathy	2.64e-05	5.89e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	2.64e-05	5.88e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—RAF1—dilated cardiomyopathy	2.63e-05	5.86e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.63e-05	5.86e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	2.63e-05	5.86e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	2.61e-05	5.82e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.6e-05	5.78e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.6e-05	5.78e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.59e-05	5.78e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.58e-05	5.75e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	2.56e-05	5.7e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.56e-05	5.7e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.54e-05	5.66e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.53e-05	5.64e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.53e-05	5.63e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—RAF1—dilated cardiomyopathy	2.52e-05	5.61e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	2.52e-05	5.61e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.49e-05	5.55e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.49e-05	5.54e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—RAF1—dilated cardiomyopathy	2.48e-05	5.53e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	2.47e-05	5.49e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	2.43e-05	5.4e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	2.42e-05	5.39e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	2.42e-05	5.39e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	2.41e-05	5.38e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	2.41e-05	5.36e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	2.38e-05	5.31e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	2.38e-05	5.3e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	2.38e-05	5.29e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.34e-05	5.22e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—EGFR—dilated cardiomyopathy	2.34e-05	5.21e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.31e-05	5.15e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.27e-05	5.05e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.26e-05	5.04e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.25e-05	5.01e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	2.24e-05	4.98e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	2.24e-05	4.98e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	2.21e-05	4.92e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.19e-05	4.88e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.15e-05	4.8e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	2.13e-05	4.75e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	2.08e-05	4.64e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	2.08e-05	4.63e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	2.03e-05	4.52e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	2.02e-05	4.5e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.99e-05	4.42e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.96e-05	4.37e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.95e-05	4.35e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.95e-05	4.34e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.95e-05	4.34e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.94e-05	4.33e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	1.94e-05	4.32e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.94e-05	4.32e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.92e-05	4.27e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.91e-05	4.26e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.91e-05	4.26e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	1.89e-05	4.2e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	1.87e-05	4.17e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.86e-05	4.13e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.83e-05	4.07e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—EGFR—dilated cardiomyopathy	1.81e-05	4.02e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	1.8e-05	4.02e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	1.79e-05	3.99e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.78e-05	3.96e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.75e-05	3.91e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—EGFR—dilated cardiomyopathy	1.73e-05	3.85e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.72e-05	3.83e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.71e-05	3.81e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—EGFR—dilated cardiomyopathy	1.7e-05	3.79e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.68e-05	3.75e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.68e-05	3.74e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.67e-05	3.73e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.67e-05	3.72e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.65e-05	3.68e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.65e-05	3.67e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	1.63e-05	3.63e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.55e-05	3.46e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	1.53e-05	3.42e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.53e-05	3.42e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.53e-05	3.41e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.38e-05	3.08e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.34e-05	2.98e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.33e-05	2.96e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.29e-05	2.88e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.28e-05	2.86e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.27e-05	2.84e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.25e-05	2.78e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.17e-05	2.61e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.15e-05	2.57e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.15e-05	2.57e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.15e-05	2.56e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.14e-05	2.55e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.13e-05	2.53e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.13e-05	2.52e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.12e-05	2.51e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.05e-05	2.34e-05	CbGpPWpGaD
